| Literature DB >> 27461103 |
Isaac R Kasper1, Sokratis A Apostolidis2, Amir Sharabi3, George C Tsokos4.
Abstract
Regulatory T cells (Tregs) are capable of dampening immune-mediated inflammation and avert the destructive effects of uncontrolled inflammation. Distinct molecules and pathways, including various transcription factors, phosphatases, and kinases, impact the ability of Tregs to function as negative regulators of the immune response, and are presumably amenable to therapeutic manipulation. Here, we discuss recently identified molecular networks and the therapeutic potential for treating autoimmune diseases.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27461103 PMCID: PMC5003773 DOI: 10.1016/j.molmed.2016.07.003
Source DB: PubMed Journal: Trends Mol Med ISSN: 1471-4914 Impact factor: 11.951